Greenland Mines Ltd: Company changed its name from Klotho Neurosciences, Inc. to Greenland Mines Ltd via a Certificate of Ownership and Merger filed under Section 253(b) of the DGCL (effective 2026-03-11).
“On March 11, 2026, the registrant, then known as Klotho Neurosciences, Inc. (the “Company”) filed a Certificate of Ownership and Merger with the Secretary of State of the State of Delaware to merge the Company’s newly formed GML Subsidiary Corp. into the Company, with the Company being the surviving entity and effectuating, pursuant to Section 253(b) of the Delaware General Corporation Law, a change in the Company’s name from Klotho Neurosciences, Inc. to Greenland Mines Ltd.”
Governance Changes
Greenland Mines Ltd: Designated Series C Preferred Stock, authorizing 50,000 shares with dividend, voting, and conversion rights (effective 2026-03-04).
“On March 4, 2026, the Board of Directors of the Company, pursuant to a Certificate of Designation, designated a new series of the Company’s preferred stock to be known as Series C Preferred Stock (the “Certificate of Designation”).”
Material Agreements
Greenland Mines Ltd entered into Agreement and Plan of Merger with Greenland Mines Corp., a Delaware corporation valued at 47,000 newly issued shares of the Company’s Series C Preferred Stock (effective 2026-03-04).
“On March 4, 2026, Klotho Neurosciences, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Greenland Mines Corp., a Delaware corporation (“Greenland Mines”).”
M&A Transactions
Greenland Mines Ltd completed an acquisition involving Greenland Mines Corp. for 47,000 newly issued shares of the Company’s Series C Preferred Stock (closed 2026-03-04).
“with Greenland Mines being the surviving entity. Pursuant to the Merger Agreement, as consideration for the Merger, the stockholders of Greenland Mines will receive a total of 47,000 newly issued shares of the Company’s Series C Preferred Stock. In addition, the stockholders of Greenland Mines have the right to designate one individual to join the Company’s”
Material Agreements
Greenland Mines Ltd entered into Securities Purchase Agreement with 10 investors (effective 2026-02-19).
“On February 19, 2026, Klotho Neurosciences, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Agreement”) with 10 investors pursuant to which the Company agreed to issue and sell to the investors, at a closing, a total of 34,551,939 shares of the Company’s common stock at the Nasdaq official closing price for the prior five trading days of $0.2243 per share.”
Listing & Compliance Notices
Greenland Mines Ltd received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
“September 19, 2025, Klotho Neurosciences, Inc. (the “Company”) received a delinquency notification letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) due to the failure of the Company’s common stock to maintain a minimum bid price of $1 per share for 30 consecutive business days as required by Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until March 18, 2026, to regain compliance. To regain compliance, prior to March 18, 2026, the closing bid price of the Company’s common stock must be a”
Listing & Compliance Notices
Greenland Mines Ltd received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).
“July 14, 2025, Klotho Neurosciences, Inc. (the “Company”), received a letter from the Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum $1.00 bid price under NASDAQ Listing Rule 5550(a)(2), and the minimum stockholders’ equity threshold of $2.5 million under Listing Rule 5550(b)(1). In addition, on July 14. 2025, Nasdaq approved the Company’s application to “phase down” the listing of its common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market. The Company’s common stock will continue to trade under”
Listing & Compliance Notices
Greenland Mines Ltd received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).
“July 14, 2025, Klotho Neurosciences, Inc. (the “Company”), received a letter from the Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum $1.00 bid price under NASDAQ Listing Rule 5550(a)(2), and the minimum stockholders’ equity threshold of $2.5 million under Listing Rule 5550(b)(1). In addition, on July 14. 2025, Nasdaq approved the Company’s application to “phase down” the listing of its common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market. The Company’s common stock will continue to trade under”
Riad El-Dada was appointed as Director at Greenland Mines Ltd.
“On November 19, 2024, the Board of Directors of Klotho Neurosciences, Inc. (the “Company”) appointed Riad El-Dada to the Board of Director to fill a vacancy on the Board of Directors with a term expiring at the Company’s next Annual Meeting of Stockholders.”
Edward Cong Wang resigned as Director at Greenland Mines Ltd.
“On August 25, 2024, Edward Cong Wang resigned as a member of the Company’s Board of Directors.”
Peter Moriarty was appointed as Chief Operating Officer at Greenland Mines Ltd.
“Also on August 15, 2024, Peter Moriarty was appointed as the Company’s Chief Operating Officer.”
Jeffrey LeBlanc was appointed as Chief Financial Officer at Greenland Mines Ltd.
“On August 15, 2024, Jeffrey LeBlanc was appointed as the Company’s Chief Financial Officer.”
Edward Cong Wang resigned as interim Chief Financial Officer at Greenland Mines Ltd.
“On July 30, 2024, Edward Cong Wang, the Company’s interim Chief Financial Officer, resigned from that position.”
Material Agreements
Greenland Mines Ltd entered into Non-Redemption Agreement with certain investors named therein (each, a Backstop Investor) (effective 2024-05-09).
“On May 9, 2024, Redwoods Acquisition Corp. (“ RWOD ” or “ Redwoods ”) entered into a non-redemption agreement (the “ Non-Redemption Agreement ”) with certain investors named therein (each, a “ Backstop Investor ”), each acting on behalf of certain funds, investors, entities or accounts that are managed, sponsored or advised by each such Backstop Investor or its affiliates.”
Shareholder Votes
Greenland Mines Ltd shareholders approved Proposal 6 - approval for purposes of Nasdaq Listing Rule 5635(a) and (b) of issuance of more than 20% of common stock and resulting change in control in connection with the Transactions at the 2024-04-12 meeting.
“Proposal 6- A proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(a) and (b), the issuance of more than 20% of the issued and outstanding Company common stock and the resulting change in control in connection with the Transactions 4,185,875 3,152 0”
Shareholder Votes
Greenland Mines Ltd shareholders approved Proposal 5 - election of five directors to serve on the combined company's board effective as of closing at the 2024-04-12 meeting.
“Proposal 5- A proposal to elect five directors to serve on the combined company's board of directors effective as of the closing of the transactions in accordance with the Business Combination Agreement. NOMINEE FOR WITHHELD 5a) Joseph Sinkule 4,138,720 50,307 5b) Shalom Z. Hirschman 4,189,023 4 5c) Samuel Zentman 4,189,023 4 5d) Jon W. McGarity 4,189,023 4 5e) Edward Cong Wang 4,189,023 4”
Shareholder Votes
Greenland Mines Ltd shareholders approved Proposal 4 - adoption of ANEW MEDICAL, INC. 2023 Stock Incentive Plan at the 2024-04-12 meeting.
“Proposal 4- A proposal to adopt the ANEW MEDICAL, INC. 2023 Stock Incentive Plan, and the material terms thereof, including the authorization of the initial share reserve thereunder. 4,135,672 53,355 0”
Shareholder Votes
Greenland Mines Ltd shareholders approved Proposal 3 - non-binding advisory approval of certain governance provisions in the second amended and restated certificate of incorporation at the 2024-04-12 meeting.
“Proposal 3- A proposal to approve, on a non-binding advisory basis, certain governance provisions in the second amended and restated certificate of incorporation, presented separately in accordance with the United States Securities and Exchange Commission ("SEC") requirements 4,135,672 53,355 0”
Shareholder Votes
Greenland Mines Ltd shareholders approved Proposal 2 - approval and adoption of second amended and restated certificate of incorporation at the 2024-04-12 meeting.
“Proposal 2- A proposal to approve and adopt the second amended and restated certificate of incorporation. 4,135,672 53,355 0”
Shareholder Votes
Greenland Mines Ltd shareholders approved Proposal 1 - approval of the business combination, including adopting the Business Combination Agreement and approving the other transactions at the 2024-04-12 meeting.
“Proposal 1 - A proposal to approve the business combination, including (a) adopting the Business Combination Agreement and (b) approving the other transactions contemplated by the Business Combination Agreement and related agreements. 4,185,975 3,052 0”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.